Target intelligence / Profile preview

Pneumococcal capsular polysaccharides (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F) (PCV7 antigens)

Target
PCV7 antigens
Molecular classification
Polysaccharide, Bacterial antigen
01

Overview

Pneumococcal capsular polysaccharides (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F) are the complex carbohydrate structures that form the outermost layer of Streptococcus pneumoniae bacteria (Source: NIH, CDC). These polysaccharides are the primary virulence factors of the pathogen, as they protect the bacteria from host immune recognition and inhibit phagocytosis by neutrophils and macrophages (Source: PubMed, ATCC). There are over 100 known serotypes of S. pneumoniae, but the specific group of seven (4, 6B, 9V, 14, 18C, 19F, and 23F) was historically responsible for the majority of invasive pneumococcal disease (IPD) in children worldwide (Source: CDC, NIH). These polysaccharides serve as the antigenic components in vaccines, most notably the first pneumococcal conjugate vaccine, PCV7 (Source: FDA). When administered, they stimulate the production of serotype-specific antibodies that opsonize the bacteria, allowing the immune system to effectively clear the infection (Source: StatPearls, WHO). While highly effective at reducing disease caused by these specific serotypes, their use has led to 'serotype replacement,' where non-vaccine serotypes fill the ecological niche left by the targeted strains (Source: PubMed).

Other names
Streptococcus pneumoniae capsular polysaccharidesPneumococcal polysaccharidesPneumococcal capsular antigensPCV7 serotypesCPS
02

Mechanism of action

These polysaccharides act as antigens that stimulate the production of serotype-specific antibodies. In conjugate vaccines (PCVs), the polysaccharides are covalently linked to a carrier protein (such as CRM197), which converts the T-cell independent polysaccharide into a T-cell dependent antigen. This process induces a robust immune response, including the production of high-affinity IgG antibodies and the creation of B-cell memory. These antibodies opsonize the Streptococcus pneumoniae capsule, facilitating its recognition and destruction by phagocytic cells like macrophages and neutrophils (Source: NIH, StatPearls).

03

Biological functions

Immune evasionVirulence factorAntiphagocytic activityBacterial encapsulation
04

Disease associations

PneumoniaMeningitisBacteremiaSepsisOtitis mediaInvasive pneumococcal disease (IPD)
05

Safety considerations

Serotype replacement (emergence of non-vaccine serotypes)Injection site reactions (pain, redness, swelling)FeverIrritabilityHypersensitivity reactions
06

Interacting drugs

Pneumococcal 7-valent Conjugate Vaccine (Prevnar)

4 more in the full profile.

07

Biomarkers

Serotype-specific IgG antibody titersOpsonophagocytic activity (OPA) titers

Beyond the preview

Go deeper on Pneumococcal capsular polysaccharides (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F) (PCV7 antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pneumococcal capsular polysaccharides (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F) (PCV7 antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call